General Information of This Antigen (ID: TAR0JNOKW)
Antigen Name
CD44 antigen (CD44)
Gene Name
CD44
Gene ID
960
Synonym
LHR; MDU2; MDU3; MIC4; CDw44;Epican;Extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HUTCH-I;Heparan sulfate proteoglycan;Hermes antigen;Hyaluronate receptor;Phagocytic glycoprotein 1;Phagocytic glycoprotein I;CD44
Sequence
MDKFWWHAAWGLCLVPLSLAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTL
PTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFN
ASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDVSS
GSSSERSSTSGGYIFYTFSTVHPIPDEDSPWITDSTDRIPATTLMSTSATATETATKRQE
TWDWFSWLFLPSESKNHLHTTTQMAGTSSNTISAGWEPNEENEDERDRHLSFSGSGIDDD
EDFISSTISTTPRAFDHTKQNQDWTQWNPSHSNPEVLLQTTTRMTDVDRNGTTAYEGNWN
PEAHPPLIHHEHHEEEETPHSTSTIQATPSSTTEETATQKEQWFGNRWHEGYRQTPKEDS
HSTTGTAAASAHTSHPMQGRTTPSPEDSSWTDFFNPISHPMGRGHQAGRRMDMDSSHSIT
LQPTANPNTGLVEDLDRTGPLSMTTQQSNSQSFSTSHEGLEEDKDHPTTSTLTSSNRNDV
TGGRRDPNHSEGSTTLLEGYTSHYPHTKESRTFIPVTSAKTGSFGVTAVTVGDSNSNVNR
SLSGDQDTFHPSGGSHTTHGSESDGHSHGSQEGGANTTSGPIRTPQIPEWLIILASLLAL
ALILAVCIAVNSRRRCGQKKKLVINSGNGAVEDRKPSGLNGEASKSQEMVHLVNKESSET
PDQFMTADETRNLQNVDMKIGV

    Click to Show/Hide
Function
Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment. Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection. Engages, through its ectodomain, extracellular matrix components such as hyaluronan/HA, collagen, growth factors, cytokines or proteases and serves as a platform for signal transduction by assembling, via its cytoplasmic domain, protein complexes containing receptor kinases and membrane proteases. Such effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and phospholipase C that coordinate signaling pathways promoting calcium mobilization and actin-mediated cytoskeleton reorganization essential for cell migration and adhesion.

    Click to Show/Hide
Uniprot Entry
CD44_HUMAN
HGNC ID
HGNC:1681
KEGG ID
hsa:960
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Bivatuzumab
ADC Name Payload Target Linker ADC Info
Bivatuzumab mertansine
DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Bivatuzumab-ADC-24-1 [1]
Bivatuzumab-ADC-24-1 payload
Undisclosed
Bivatuzumab-ADC-24-1 linker
Bivatuzumab-ADC-24-2 [1]
Bivatuzumab-ADC-24-2 payload
Undisclosed
Bivatuzumab-ADC-24-2 linker
Bivatuzumab-ADC-24-3 [1]
Bivatuzumab-ADC-24-3 payload
Undisclosed
Bivatuzumab-ADC-24-3 linker
Bivatuzumab-ADC-24-4 [1]
Bivatuzumab-ADC-24-4 payload
Undisclosed
Bivatuzumab-ADC-24-4 linker
Bivatuzumab-ADC-24-5 [1]
Bivatuzumab-ADC-24-5 payload
Undisclosed
Bivatuzumab-ADC-24-5 linker
Bivatuzumab-ADC-24-6 [1]
Bivatuzumab-ADC-24-6 payload
Undisclosed
Bivatuzumab-ADC-24-6 linker
Bivatuzumab-ADC-24-7 [1]
Bivatuzumab-ADC-24-7 payload
Undisclosed
Bivatuzumab-ADC-24-7 linker
Bivatuzumab-ADC-24-8 [1]
Bivatuzumab-ADC-24-8 payload
Undisclosed
Bivatuzumab-ADC-24-8 linker
Bivatuzumab-ADC-24-9 [1]
Bivatuzumab-ADC-24-9 payload
Undisclosed
Bivatuzumab-ADC-24-9 linker
Bivatuzumab-ADC-24-10 [1]
Bivatuzumab-ADC-24-10 payload
Undisclosed
Bivatuzumab-ADC-24-10 linker
Bivatuzumab-ADC-24-11 [1]
Bivatuzumab-ADC-24-11 payload
Undisclosed
Bivatuzumab-ADC-24-11 linker
Bivatuzumab-ADC-24-12 [1]
Bivatuzumab-ADC-24-12 payload
Undisclosed
Bivatuzumab-ADC-24-12 linker
Bivatuzumab-ADC-24-13 [1]
Bivatuzumab-ADC-24-13 payload
Undisclosed
Bivatuzumab-ADC-24-13 linker
ADC Name Payload Target Linker ADC Info
H1D8-DC [2]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
ADC Name Payload Target Linker ADC Info
HIS092-vc-MMAE [3]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Undisclosed
ADC Name Payload Target Linker ADC Info
AMT-029 [4]
Undisclosed
Undisclosed
Undisclosed
CD44-IR700 [5]
IRDye 700DX
Undisclosed
Undisclosed
CD44-VCMMAE [6]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
CD44-MMAE [6]
Monomethyl auristatin E
Microtubule (MT)
CN117362435A+SCD44-MMAE+Linker
CD44-DRT [6]
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
CN117362435A+CD44-DRT+Linker
CD44-DOXHZN [6]
DOXHZN
Undisclosed
CN117362435A+CD44-DOXHZN+Linker
CD44-DM1 [6]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
CD44-SPB [6]
SPB
Undisclosed
CN117362435A+CD44-SPB+Linker
CD44-SN-38 [6]
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CN117362435A+CD44-SN-38+Linker
CD44-DXTS [6]
Dexamethasone
Glucocorticoid receptor (NR3C1)
3-Maleimidopropionic acid linker
CD44-DOTA [6]
Undisclosed
Undisclosed
Undisclosed
CD44-INNO-20 [6]
Aldoxorubicin (INNO-206)
Undisclosed
6-Maleimidocaproic acid
References
Ref 1 Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof; 2020-04-02.
Ref 2 Targeting CD44 Variant 5 with an Antibody-Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
Ref 3 CD44-specific antibodies
Ref 4 Introduction to basic information on ADC drug AMT-029.
Ref 5 Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugates
Ref 6 CD44-specific antibodies and their antibody-drug conjugates